电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Recombinant SARS-CoV-2 Spike 抗体 (AA 319-541)

This anti-SARS-CoV-2 Spike antibody is a 小鼠 单克隆 antibody detecting SARS-CoV-2 Spike in ELISA, WB, FACS 和 IF. Suitable for SARS Coronavirus-2 (SARS-CoV-2).
产品编号 ABIN7581775
发货至: 中国

Quick Overview for Recombinant SARS-CoV-2 Spike 抗体 (AA 319-541) (ABIN7581775)

抗原

See all SARS-CoV-2 Spike 抗体
SARS-CoV-2 Spike

抗体类型

Recombinant Antibody

适用

  • 120
  • 7
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
SARS Coronavirus-2 (SARS-CoV-2)

宿主

  • 54
  • 31
  • 30
  • 3
  • 2
  • 2
  • 1
  • 1
小鼠

克隆类型

  • 92
  • 18
  • 11
单克隆

标记

  • 98
  • 18
  • 3
  • 1
  • 1
This SARS-CoV-2 Spike antibody is un-conjugated

应用范围

  • 100
  • 53
  • 25
  • 13
  • 9
  • 7
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
ELISA, Western Blotting (WB), Flow Cytometry (FACS), Immunofluorescence (IF)

质量等级

Animal-Free

克隆位点

AB68-A09
  • 抗原表位

    • 64
    • 11
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 319-541

    Expression System

    Phage display

    原理

    recombinant anti-SARS-CoV-2 spike antibody

    特异性

    This is an antibody developed by antibody phage display technology using a human naive antibody gene library and SARS-CoV-2 antigen. For this antibody both the heavy and light chains are cloned and expressed, generating full-length antibodies.

    交叉反应 (详细)

    No known cross reactivity. No cross-reactivity to other human coronaviruses.

    产品特性

    This antibody can be detected with anti-mouse Fc secondary antibodies.

    纯化方法

    Protein A purification

    免疫原

    No immunization, animal-free antibody development. Antigen: Spike Protein SARS-CoV2 RVQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIADYNYKLPDDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNF

    亚型

    IgG2a
  • 应用备注

    Western Blot: 0.2-5 μg/mL ELISA: 1-12 μg/mL as coating antibody 0.5-5 μg/mL as detection antibody IF: 0.1 - 10 μg/mL Optimal working dilution should be determined by the investigator

    限制

    仅限研究用
  • 状态

    Liquid

    浓度

    1 mg/mL

    缓冲液

    PBS, pH 7.4,

    储存条件

    -20 °C
  • 抗原

    SARS-CoV-2 Spike

    别名

    SARS-CoV-2 spike protein (RBD)

    背景

    Coronaviruses (CoVs) are enveloped non-segmented positive-sense single-stranded RNA viruses and can infect respiratory, gastrointestinal, hepatic and central nervous system of human and many other wild animals. Recently, a new severe acute respiratory syndrome β-coronavirus called SARS-CoV-2 (or 2019-nCoV) has emerged, which causes an epidemic of acute respiratory syndrome (called coronavirus human disease 2019 or COVID-19). SARS-CoV-2 shares 79.5 % sequence identity with SARS-CoV and is 96.2 % identical at the genome level to the bat coronavirus BatCoV RaTG133, suggesting it had originated in bats. SARS-CoV-2 contains 4 structural proteins, including Envelope (E), Membrane (M), Nucleocapsid (N) and Spike (S), which is a transmembrane protein, composed of two subunits S1 and S2. The S protein plays a key role in viral infection and pathogenesis. The S1 subunit contains the N-terminal domain (NTD) and a receptor binding domain (RBD), which binds to the cell surface receptor Angiotensin-Converting Enzyme 2 (ACE2) present at the surface of epithelial cells, causing mainly infection of human respiratory cells, whereas S2 harbors heptad repeat 1 (HR1) and HR2. The RBD domain first binds its receptor to form an RBD/ACE2 complex. This triggers conformational changes in the S protein, leading to membrane fusion mediated via HR1 and HR2 and consequently in viral entry into target cells. Antibodies targeting various regions of S protein have different mechanisms in inhibiting SARS-CoV-2 infection. For example, NTD-targeting antibodies bind the NTD to form an NTD/mAb complex, thereby preventing conformational changes in the S protein and blocking membrane fusion and viral entry. RBD-targeting antibodies form RBD/mAb or RBD/Nb complexes that could inhibit binding of the RBD to ACE2, thereby preventing entry of SARS-CoV-2 into target cells.

    分子量

    76 kDa

    NCBI登录号

    YP_009724390

    UniProt

    P0DTC2
You are here:
Chat with us!